Moonlake Immunotherapeutics logo

Moonlake Immunotherapeutics Share Price Today

(NASDAQ: MLTX)

Moonlake Immunotherapeutics share price is $40.73 & ₹3,547.99 as on 26 Feb 2025, 2.30 'hrs' IST

$40.73

-0.23

(-0.56%)

Market is closed - opens 8 PM, 26 Feb 2025

View live Moonlake Immunotherapeutics share price in Dollar and Rupees. Guide to invest in Moonlake Immunotherapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Moonlake Immunotherapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Moonlake Immunotherapeutics share price movements

  • Today's Low: $39.99
    Today's High: $41.36

    Day's Volatility :3.31%

  • 52 Weeks Low: $37.55
    52 Weeks High: $58.26

    52 Weeks Volatility :35.55%

Moonlake Immunotherapeutics (MLTX) Returns

PeriodMoonlake ImmunotherapeuticsIndex (Russel 2000)
3 Months
-24.48%
0.0%
6 Months
-12.5%
0.0%
1 Year
-25.2%
0.0%
3 Years
234.37%
-13.3%

Moonlake Immunotherapeutics (MLTX) Key Statistics

in dollars & INR

Previous Close
$40.96
Open
$40.88
Today's High
$41.36
Today's Low
$39.99
Market Capitalization
$2.6B
Today's Volume
$331.4K
52 Week High
$58.26
52 Week Low
$37.55
Revenue TTM
$0.0
EBITDA
$-108.5M
Earnings Per Share (EPS)
$-1.27
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-16.8%

How to invest in Moonlake Immunotherapeutics Stock (MLTX) from India?

It is very easy for Indian residents to invest directly in Moonlake Immunotherapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Moonlake Immunotherapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Moonlake Immunotherapeutics or MLTX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Moonlake Immunotherapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Moonlake Immunotherapeutics shares which would translate to 0.021 fractional shares of Moonlake Immunotherapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Moonlake Immunotherapeutics, in just a few clicks!

Returns in Moonlake Immunotherapeutics (MLTX) for Indian investors in Rupees

The Moonlake Immunotherapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Moonlake Immunotherapeutics investment value today

Current value as on today

₹79,470

Returns

₹20,530

(-20.53%)

Returns from Moonlake Immunotherapeutics Stock

₹25,621 (-25.62%)

Dollar Returns

₹5,091 (+5.09%)

Indian investors sentiment towards Moonlake Immunotherapeutics (MLTX)

50%

Period: Jan 26, 2025 to Feb 25, 2025. Change in 30 Days versus previous period

Search interest for Moonlake Immunotherapeutics Stock from India on INDmoney has increased by 50% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Moonlake Immunotherapeutics

  • Bvf Inc

    31.32%

  • Cormorant Asset Management, LLC

    13.47%

  • FMR Inc

    10.06%

  • T. Rowe Price Associates, Inc.

    5.30%

  • venBio Select Advisor LLC

    4.39%

  • Citadel Advisors Llc

    3.68%

Analyst Recommendation on Moonlake Immunotherapeutics

Buy

    81%Buy

    18%Hold

    0%Sell

Based on 22 Wall street analysts offering stock ratings for Moonlake Immunotherapeutics(by analysts ranked 0 to 5 stars)

Based on 22 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
18
18
17
Hold
4
3
3
Sell
0
0
0

Analyst Forecast on Moonlake Immunotherapeutics Stock (MLTX)

What analysts predicted

Upside of 91.51%

Target:

$78.00

Current:

$40.73

Insights on Moonlake Immunotherapeutics Stock (Ticker Symbol: MLTX)

  • Price Movement

    In the last 3 months, MLTX stock has moved down by -24.4%
  • MLTX vs ONC (1 yr)

    In the last 1 year, Beone Medicines Ltd has given 66.7% return, outperforming this stock by 88.0%

Moonlake Immunotherapeutics Technicals Summary

Sell

Neutral

Buy

Moonlake Immunotherapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Moonlake Immunotherapeutics (MLTX) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Moonlake Immunotherapeutics logo
-8.75%
-12.5%
-25.2%
234.37%
234.37%
Regeneron Pharmaceuticals, Inc. logo
4.17%
-40.53%
-28.2%
15.35%
60.44%
Beone Medicines Ltd logo
14.76%
30.45%
43.85%
22.79%
63.24%
Vertex Pharmaceuticals Incorporated logo
8.51%
-1.65%
11.77%
109.39%
114.99%
Alnylam Pharmaceuticals, Inc. logo
-10.04%
-11.31%
56.57%
57.71%
111.58%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Moonlake Immunotherapeutics logo
NA
NA
NA
-1.72
-0.17
-0.13
NA
7.74
Regeneron Pharmaceuticals, Inc. logo
18.28
18.28
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
-5.69
-0.23
-0.1
NA
226.72
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.11
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.59
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Moonlake Immunotherapeutics logo
Buy
$2.6B
234.37%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$76.6B
60.44%
18.28
31.07%
Beone Medicines Ltd logo
NA
$29.9B
63.24%
NA
-25.5%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.3B
114.99%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$32.4B
111.58%
NA
-12.37%

Moonlake Immunotherapeutics Dividend announcements

  • Moonlake Immunotherapeutics Earnings

    Moonlake Immunotherapeutics’s price-to-earnings ratio stands at None

    Read More

About Moonlake Immunotherapeutics

MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It develops Sonelokimab, a novel investigational Nanobody for the treatment of inflammation diseases; and hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, and psoriasis. MoonLake Immunotherapeutics was founded in 2021 and is headquartered in Zug, Switzerland.
Organization
Moonlake Immunotherapeutics
Employees
50
CEO
Dr. Jorge Santos da Silva
Industry
Miscellaneous

Management People of Moonlake Immunotherapeutics

NameTitle
Dr. Jorge Santos da Silva
Co-Founder, CEO & Director
Dr. Kristian Reich
Co-Founder & Chief Scientific Officer
Mr. Matthias Bodenstedt
Chief Financial Officer
Mr. Oliver Daltrop Ph.D.
Chief Operations Officer
Ms. Carla Bretes
Director Investor Relations & Business Development
Mr. Nicolas Mosimann
General Counsel
Joana Cortez
Sr. Director Legal & Compliance
Tino Anthamatten
Vice President of Marketing, Market Access & Pricing
Luciana Marques
Director of HR, People & Culture
Ms. Nuala Brennan
Chief Clinical Development Officer

Important FAQs about investing in MLTX Stock from India :

What is Moonlake Immunotherapeutics share price today?

Moonlake Immunotherapeutics share price today stands at $40.73, Open: $40.88 ; Previous Close: $40.96 ; High: $41.36 ; Low: $39.99 ; 52 Week High: $58.26 ; 52 Week Low: $37.55.

The stock opens at $40.88, after a previous close of $40.96. The stock reached a daily high of $41.36 and a low of $39.99, with a 52-week high of $58.26 and a 52-week low of $37.55.

Can Indians buy Moonlake Immunotherapeutics shares?

Yes, Indians can invest in the Moonlake Immunotherapeutics (MLTX) from India.

With INDmoney, you can buy Moonlake Immunotherapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Moonlake Immunotherapeutics at zero transaction cost.

How can I buy Moonlake Immunotherapeutics shares from India?

It is very easy to buy Moonlake Immunotherapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Moonlake Immunotherapeutics (MLTX) be purchased?

Yes, you can buy fractional shares of Moonlake Immunotherapeutics with INDmoney app.

What are the documents required to start investing in Moonlake Immunotherapeutics stocks?

To start investing in Moonlake Immunotherapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Moonlake Immunotherapeutics Stock (MLTX)?

Today’s highest price of Moonlake Immunotherapeutics (MLTX) is $41.36.

Today’s lowest price of Moonlake Immunotherapeutics (MLTX) is $39.99.

What is today's market capitalisation of Moonlake Immunotherapeutics?

Today's market capitalisation of Moonlake Immunotherapeutics MLTX is 2.6B

What is the 52 Week High and Low Range of Moonlake Immunotherapeutics Stock (MLTX)?

  • 52 Week High

    $58.26

  • 52 Week Low

    $37.55

What are the historical returns of Moonlake Immunotherapeutics (MLTX)?

  • 1 Month Returns

    -8.75%

  • 3 Months Returns

    -12.5%

  • 1 Year Returns

    -25.2%

  • 5 Years Returns

    234.37%

Who is the Chief Executive Officer (CEO) of Moonlake Immunotherapeutics ?

Dr. Jorge Santos da Silva is the current Chief Executive Officer (CEO) of Moonlake Immunotherapeutics.